These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8589241)

  • 41. Relative incidence estimation from case series for vaccine safety evaluation.
    Farrington CP
    Biometrics; 1995 Mar; 51(1):228-35. PubMed ID: 7766778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose response signal detection under model uncertainty.
    Dette H; Titoff S; Volgushev S; Bretz F
    Biometrics; 2015 Dec; 71(4):996-1008. PubMed ID: 26228796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-time-response cumulative multinomial generalized linear model.
    Chen DG
    J Biopharm Stat; 2007; 17(1):173-85. PubMed ID: 17219762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation.
    Senn S; Holford N; Hockey H
    Stat Med; 2012 Dec; 31(30):4280-95. PubMed ID: 22825800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percentile regression analysis of correlated antibody responses.
    Moulton LH; Holt EA; Job JS; Halsey NA
    Stat Med; 1995 Apr; 14(8):777-87. PubMed ID: 7644858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A gamma model for extra-binomial variation in dilution assays.
    O'Neill TJ; O'Neill HC
    Biometrics; 1993 Mar; 49(1):237-42. PubMed ID: 8513105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repeated measures with zeros.
    Berk KN; Lachenbruch PA
    Stat Methods Med Res; 2002 Aug; 11(4):303-16. PubMed ID: 12197298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A mixed gamma model for regression analyses of quantitative assay data.
    Moulton LH; Halsey NA
    Vaccine; 1996 Aug; 14(12):1154-8. PubMed ID: 8911013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statistical tests for latent class in censored data due to detection limit.
    He H; Tang W; Kelly T; Li S; He J
    Stat Methods Med Res; 2020 Aug; 29(8):2179-2197. PubMed ID: 31736411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A mixture model for occupational exposure mean testing with a limit of detection.
    Taylor DJ; Kupper LL; Rappaport SM; Lyles RH
    Biometrics; 2001 Sep; 57(3):681-8. PubMed ID: 11550915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new statistical test for latent class in censored data due to detection limit.
    Zou Y; Peng Z; Cornell J; Ye P; He H
    Stat Med; 2021 Feb; 40(3):779-798. PubMed ID: 33159355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation in generalized linear models under censored covariates with an application to MIREC data.
    Lee WC; Sinha SK; Arbuckle TE; Fisher M
    Stat Med; 2018 Dec; 37(29):4539-4556. PubMed ID: 30168157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infections reveal inequality between the sexes.
    Reardon S
    Nature; 2016 Jun; 534(7608):447. PubMed ID: 27337319
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical cross-over trials in phase I.
    Senn S; Ezzet F
    Stat Methods Med Res; 1999 Sep; 8(3):263-78. PubMed ID: 10636338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Some comments on analysis techniques for censored water quality data.
    Farewell VT
    Environ Monit Assess; 1989 Nov; 13(2-3):285-94. PubMed ID: 24243177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using orthogonal polynomial scores in summarizing and evaluating longitudinal data collected in phase I and II clinical pharmacology studies.
    Bradstreet TE
    Stat Med; 1993 Apr; 12(7):633-43. PubMed ID: 8511440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The measurement and interpretation of age-specific vaccine efficacy.
    Farrington CP
    Int J Epidemiol; 1992 Oct; 21(5):1014-20. PubMed ID: 1468838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two-stage design of quantal response studies.
    Sitter RR; Wu CF
    Biometrics; 1999 Jun; 55(2):396-402. PubMed ID: 11318192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bayesian inference on protective antibody levels using case-control data.
    Carey VJ; Baker CJ; Platt R
    Biometrics; 2001 Mar; 57(1):135-42. PubMed ID: 11252588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flexible modelling of vaccine effect in self-controlled case series models.
    Ghebremichael-Weldeselassie Y; Whitaker HJ; Farrington CP
    Biom J; 2016 May; 58(3):607-22. PubMed ID: 26494534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.